The UVA Digestive Health Center offers a world-class team of medical, surgical, and pediatric liver disease specialists offering cutting-edge therapies in the treatment of advanced liver disease and liver transplantation.
Clinic team members strive to optimize the quality of life for patients with liver disease by providing comprehensive multidisciplinary care from the time of referral. The Hepatology Clinic provides a complete range of innovative diagnostic and treatment services, including the following:
Coagulation in Liver Disease
The UVA Hepatology team has internationally renowned expertise in this aspect of hepatology. Under the direction of Dr. Stephen Caldwell, a number of clinical research efforts are underway in this field. These are headed up by Patrick Northup, MD, Neeral Shah, MD, and Nic Intagliata, MD, and include University-based studies as well as international collaborations. In addition, UVA is a co-organizer of the biennial International Symposium on Coagulation in Liver Disease (http://www.coagulationinliverdisease.org/).
Non-alcoholic Fatty Liver Disease (NAFLD)
Our physicians are leaders in the clinical care of patients with fatty liver disease, including nonalcoholic steatohepatitis (NASH). There are no FDA medical therapies for this condition which may affect up to 80 million Americans. We have multiple ongoing clinical trials headed up by Dr. Zachary Henry and Dr. Stephen Caldwell to investigate newer diagnostic tests and therapies of this potentially progressive form of liver disease. In addition, we have a specific clinic to address lifestyle modifications for NASH patients with more advanced disease.
Viral Hepatitis (Hepatitis C and Hepatitis B)
Specialists in Hepatology and Infectious Disease have partnered to offer a variety of new therapies tailored to the individual patient. Strong nursing and pharmacy support have led to increased access to medical therapy for our patients with viral hepatitis.
Liver Cancer and Liver Lesions
A multidisciplinary team provides a strong clinical foundation for all forms of therapy for liver cancer and benign liver lesions — from surgical to radiological to medical. Clinical trials are underway to explore newer potential treatment options with better outcomes. Focused Hepatology tumor clinics under Feng Su, MD and Stephen Caldwell, MD, provide the starting point for patients undergoing evaluation and treatment for liver cancer.
The Liver Transplant program at the University of Virginia provides transplant care for a wide range of liver diseases. Our multi-disciplinary team includes hepatologists, transplant surgeons, nurse coordinators, social workers, registered dietitians, pharmacists, and financial coordinators to help patients and their families navigate the transplant process. Our team is led by our Medical Director, Dr. Curtis Argo, and our Surgical Director, Dr. Shawn Pelletier.
Living Donor Transplantation
UVA is one of a small number sites in the U.S. to offer this novel and life-saving form of liver transplantation. Our transplant team includes hepatologists, surgeons, pathologists, radiologists, and specialty nurse coordinators. Patients are managed by a multidisciplinary team headed up by Dr. Curtis Argo, the Medical Director of Living Donor Liver Transplantation and Dr. Nico Goldaracena, the Surgical Director of Living Donor Liver Transplantation.
Alcohol Related Liver Disease
UVA provides multidisciplinary care for individuals with alcohol related liver disease, including those with alcoholic hepatitis as well as cirrhosis. In addition to providing liver care, our providers will discuss strategies for alcohol abstinence including medications to help avoid alcohol and consultations with counselors or psychiatrists when appropriate. Dr. Matthew Stotts offers a focused clinic for the management of both alcohol related liver disease in collaboration with addiction medicine physicians at UVA.
Portal Hypertensive Bleeding
At UVA we have a multi-disciplinary team including hepatologists, interventional radiologists, and interventional endoscopists committed to the diagnosis and treatment of life threatening bleeding in patients with cirrhosis and non-cirrhotic portal hypertension. This team is led by Dr. Zachary Henry and utilizes cutting edge diagnostic tools and treatments including endoscopic cyanoacrylate (glue) injection, TIPS (transjugular intrahepatic portosystemic shunt), and BRTO (balloon-occluded retrograde transvenous obliteration).
Stephen H. Caldwell, MD
Curtis Argo, MD, MS
Neeral Shah, MD
Nicolas Intagliata, MD
Feng Su, MD
Zachary Henry, MD
Matthew J. Stotts, MD MPH
Advanced Practice Providers
Marcia Haney, RN
Amy Brown, RN
Faith Mawyer, RN
Katherine Craig, RN
Shannon Carter, RN